These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15683610)

  • 21. Spotlight on omalizumab in allergic asthma.
    Bang LM; Plosker GL
    BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab: a review of its use in the management of allergic asthma.
    Bang LM; Plosker GL
    Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-IgE treatment: an update.
    Babu KS; Arshad SH; Holgate ST
    Allergy; 2001 Dec; 56(12):1121-8. PubMed ID: 11736740
    [No Abstract]   [Full Text] [Related]  

  • 24. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
    Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G;
    JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.
    Chervinsky P; Casale T; Townley R; Tripathy I; Hedgecock S; Fowler-Taylor A; Shen H; Fox H
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):160-7. PubMed ID: 12952110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.
    Ruffin CG; Busch BE
    Am J Health Syst Pharm; 2004 Jul; 61(14):1449-59. PubMed ID: 15332692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omalizumab: efficacy in allergic disease.
    Spector S
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omalizumab: where does it fit into current asthma management?
    Rambasek TE; Lang DM; Kavuru MS
    Cleve Clin J Med; 2004 Mar; 71(3):251-61. PubMed ID: 15055248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.
    Cruz AA; Lima F; Sarinho E; Ayre G; Martin C; Fox H; Cooper PJ
    Clin Exp Allergy; 2007 Feb; 37(2):197-207. PubMed ID: 17250692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omalizumab: a review of its use in the treatment of allergic asthma.
    Plosker GL; Keam SJ
    BioDrugs; 2008; 22(3):189-204. PubMed ID: 18481901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omalizumab.
    Easthope S; Jarvis B
    Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer aspects in the treatment of pediatric and adult asthma: monoclonal anti-IgE.
    Lanier BQ
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6 Suppl 3):13-5. PubMed ID: 12839107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.
    Holgate S; Buhl R; Bousquet J; Smith N; Panahloo Z; Jimenez P
    Respir Med; 2009 Aug; 103(8):1098-113. PubMed ID: 19362459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-immunoglobulin E, a monoclonal antibody to treat respiratory disorders].
    Cabrera-Navarro P
    Arch Bronconeumol; 2006 May; 42(5):241-5. PubMed ID: 16740240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma.
    Chung KF
    Expert Opin Pharmacother; 2004 Feb; 5(2):439-46. PubMed ID: 14996639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Omalizumab in severe asthma--case report].
    Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E
    Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of omalizumab from a health plan perspective.
    Belliveau PP; Lahoz MR
    J Manag Care Pharm; 2005; 11(9):735-45. PubMed ID: 16300417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.